News | January 19, 2022
Lupin ties up with Foncoo of China
This is the company’s first partnership arrangement in China
This is the company’s first partnership arrangement in China
The artificial cornea is 100% made of non-biological materials and require no co-implantation of donor corneas and it is an ideal option for treating patients with corneal blindness
He holds nine US patents and has published in multiple peer-reviewed journals and conferences
As part of Daiichi Sankyo’s 2030 vision, it plans to strengthen its oncology portfolio
_256_384.jpg)
Extending nonsurgical treatment options for Failing Pulmonic Valve in patients with congenital heart disease using Transcatheter Pulmonary Valve
Prior to IHH, Anurag held senior leadership roles in Fortis Healthcare and Manipal Health Enterprises.
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & Director & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
The biopharmaceutical market has been on a growth curve. India is number three in the Asia Pacific market. Gaurav Kaushik, MD & CEO, Meteoric Biopharmaceuticals shares a perspective on the industry
Covaxin is formulated uniquely such that the same dosage can be administered to adults and children
The group now has 325 approvals and has so far filed over 400 ANDAs since the commencement of the filing process in FY 2003-04.
Subscribe To Our Newsletter & Stay Updated
